| |
| EXCHANGE |
New York Stock Exchange (.N) |
| SECURITY |
COV Common Stock |
 |
| INVESTMENT FIRM |
ANALYST NAME |
PHONE NUMBER |
| Barclays Capital |
Adam Feinstein |
|
| BofA-ML |
Robert Hopkins |
|
| Brean Murray, Carret & Co |
Sara Michelmore |
|
| BMO |
Joanne Wuensch |
|
| Brean Murray, Carret & Co |
Sara Michelmore |
|
| Caris & Company |
Paul Choi |
|
| CLSA |
Jonathan Palmer |
|
| Citigroup |
Matthew Dodds |
|
| Deutsche Bank |
Kristen Stewart |
|
| Gabelli & Company, Inc. |
Jeff Jonas |
|
| Goldman Sachs & Co. |
David Roman |
|
| Jefferies & Co. |
Josh Jennings |
|
| JP Morgan |
Michael Weinstein |
|
| Lazard Capital Markets |
Sean Lavin |
|
| Leerink Swann |
Rick Wise |
|
| Mizuho Securities USA |
Michael Matson |
|
| Morgan Keegan |
Lawrence Keusch |
|
| Morgan Stanley |
David Lewis |
|
| Morningstar |
Alex Morozov |
|
| Piper Jaffray |
Thomas Gunderson |
|
| Raymond James |
Jayson Bedford |
|
| RBC Capital |
Glenn Novarro |
|
| Stifel Nicolaus |
Thomas Kouchoukos |
|
| Susquehanna International Group |
David Turkaly |
|
| Covidien plc is followed by the analyst(s) listed above.
Please note that any opinions, estimates or forecasts regarding Covidien plc's
performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions
of Covidien plc or its management. Covidien plc
does not by its reference above or distribution imply its endorsement of or concurrence with such information,
conclusions or recommendations.
|
|
|
